After 23 years in business, Spinning Clock Limited is turning the page with a bold new brand identity and new headquarters. Now known simply as CLOK, the company has rebranded to reflect their values of precision, clarity and creativity – and has relocated from Nottingham to a newly converted commercial barn nestled between Center Parcs and Sherwood Pines.
Founded in 2002, the company has grown from its roots as a creative agency into a trusted partner for its client's seeking clarity, precision, and results. CLOK is proudly the same limited company that was formed 23 years ago in 2002 and…
Health Innovation West Midlands (HIWM), which accelerates the adoption and spread of transformative health innovations, is now based at PHTA Ltd – supporting innovators and local entrepreneurs to speed up development and clinical rollout. As part of the national Health Innovation Network, funded by NHS England, HIWM catalyses collaboration between academia, industry, health and care providers, commissioners and citizens, supporting the development of healthcare innovations and giving patients access to the most effective medical discoveries, sooner. Since it was established in 2013…
Edinburgh and Cambridge, UK, 8 October 2025 - Macomics Ltd, a leader in macrophage drug discovery, announces that it has validated its ENIGMAC™ platform in neurodegeneration and neuroinflammation applications.
Macomics’ ENIGMAC drug discovery platform is designed to discover therapeutic targets and unlock disease specific target biology. The platform enables identification and validation of novel targets and provides a translationally relevant path to the clinic through the development of more physiologically relevant human models combined with proprietary gene editing technology.
There is…
Medicines Discovery Catapult (MDC) has been announced as the newest Innovate UK Knowledge Transfer Partnership (KTP) Knowledge Base, helping UK life science businesses innovate and grow through strategic partnership.
MDC is uniquely placed as a Knowledge Base to provide collaborative partnerships in translational drug discovery and commercialisation. Through the programme, MDC will help life sciences businesses turn their ideas into impact, equipping them with the knowledge and capabilities needed to validate their innovations and bring game-changing solutions to patients faster.
Now in…
Kuano is now offering access to the unique insights of our Quantum Lens platform and deep expertise of the Kuano team. From pilot to program, we're here to help.
At Kuano, we set out to harness quantum and AI to design novel drugs and, in the process, built a unique platform that overcomes some of the toughest challenges in drug discovery, delivering insights simply not possible through traditional and other physics-based methods.
Through close collaboration, partners can now leverage Kuano’s fully integrated design engine (combining AI and physics-based models), intuitive visualization…
Chemify scales up operations at Health Innovation Hub
Digital chemistry company Chemify is set to embark on the next phase of its business journey with a strategic relocation to Glasgow’s newest purpose-built life science facility, Health Innovation Hub (HiH).
Chemify, a pioneer in developing technology to provide pharmaceutical, biotechnology and industrial partners with better molecules, will occupy more than 40,000 sq ft across two floors with additional space on the ground floor of HiH. This represents the largest commercial letting of the year so far for life sciences in Glasgow,…
Cambridge, UK – Qkine, Ltd., a specialist bioactive protein manufacturer with its core technology developed at the University of Cambridge, today announced the launch of its Cell Therapy Grade proteins, engineered to support the stringent requirements of cell therapy research, process development, and GMP manufacturing.Cell therapy is rapidly transforming modern medicine, offering new hope for patients with cancer, autoimmune conditions, and genetic disorders. However, the development and manufacturing of these therapies demand reagents of uncompromising quality, consistency, and safety.…
International Experts to Help Drive Company Success as it Launches its Series A fundraising
Norwich, UK, September 30 2025 – Ikarovec, a leader in ophthalmology gene therapy innovation with a sophisticated field-changing technology for the long-term relief of prevalent eye diseases, has established a world-leading Scientific Advisory Board (SAB) of retinal research and clinical care specialists. The SAB, comprising a Clinical Translation Council and a Discovery Research Council, will advise the company across its activities from preclinical research through to clinical trials, regulatory…
Looking Forward to a Golden Autumn
Welcome to this month's eNews
Tony Jones, CEO, One Nucleus
It is hard to describe the news flow and activity in the Life Sciences sector as anything but an emotional rollercoaster for most in the sector. The worrisome news of large Pharma withdrawing or placing under review R&D investment in the UK, along with continuing news of financing challenges and staff redundancies, has profound implications for many.
There have been some brighter activities too. Deals completed, vacancies advertised, energetic gatherings reminding us that the…
Learn to Discover (L2D) is a cutting edge, fully supported online training course and learning platform, empowering researchers with powerful knowledge and skills to unlock their data. Our modules cover:Python programmingData handlingNetwork scienceMachine learning Artificial Intelligence (AI) Our courses are tailored for health, disease and bioscience researchers and industry. The course is accredited for CPD purposes by the Federation of the Royal Colleges of Physicians…